Roxadustat (INN, trade name Evrenzo in Japan) is an anti-anemia drug. it is a medication used for the treatment of anemia associated with chronic kidney disease (CKD) in dialysis patients. Reference standards of Roxadustat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Roxadustat
Catalogue No.:PA 18 1260000
CAS :
Molecular Formula : C19H16N2O5
Molecular Weight : 352.35
(1a-Methyl-6-oxo-3-phenoxy-1,1a,6,6a-tetrahydroindeno[1,2-b]azirine-6a-carbonyl)glycine
Catalogue No.:PA 18 1261000
(4-Hydroxy-1-methyl-7-phenoxy-5,6,7,8-tetrahydroisoquinoline-3-carbonyl)glycine
Catalogue No.:PA 18 1261001
Molecular Formula : C19H20N2O5
Molecular Weight : 356.38
4-Phenoxyphthalic Acid
Catalogue No.:PA 18 1261002
Molecular Formula : C14H10O5
Molecular Weight : 258.23
2-(Butoxycarbonyl)-5-phenoxybenzoic Acid
Catalogue No.:PA 18 1261003
Molecular Formula : C18H18O5
Molecular Weight : 314.34
Methyl 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylate
Catalogue No.:PA 18 1261004
Molecular Formula : C18H15NO4
Molecular Weight : 309.32
4-Hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylic Acid
Catalogue No.:PA 18 1261005
Molecular Formula : C17H13NO4
Molecular Weight : 295.29
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....